THE IMPACT OF CHRONIC STRESS ON THE GUT-BRAIN AXIS: A REVIEW
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6866Keywords:
Gut Microbiota, SCFAs, Hypothalamic-Pituitary-Adrenal Axis, Neuroimmune Interactions, DysbiosisAbstract
Aim of the study: The aim of this article is to review the literature on the relationship between the gut–brain axis and chronic stress, with particular emphasis on the key components and mechanisms of this system.
Materials and methods: This study is a narrative review based on current literature retrieved primarily from the PubMed database. Original research articles and review papers published in English were included. Studies were selected according to their relevance to chronic stress and its impact on gut–brain axis functioning and associated mechanisms.
Results: Chronic stress disrupts the gut–brain axis by altering gut microbiota composition, increasing intestinal permeability, and promoting systemic inflammation. These changes impair bidirectional communication between the gut and the brain, leading to neuroendocrine and immune dysregulation and increasing susceptibility to neuropsychiatric disorders such as depression. Microbial metabolites, particularly short-chain fatty acids, play an important role in these processes and may represent potential therapeutic targets.
Conclusions: Gut–brain axis disorders result from complex interactions between the nervous, immune, and metabolic systems, with gut microbiota playing a key regulatory role. Although evidence supports its influence on stress responses and neuropsychiatric vulnerability, the underlying mechanisms are not yet fully understood. Further research is needed to clarify causal relationships and to develop targeted therapeutic strategies integrating microbiota modulation with stress regulation.
References
McEwen, B. S. (2017). Neurobiological and systemic effects of chronic stress. Chronic Stress (Thousand Oaks, Calif.), 1, 2470547017692328. https://doi.org/10.1177/2470547017692328
Liu, L., Huh, J. R., & Shah, K. (2022). Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS. EBioMedicine, 77, 103908. https://doi.org/10.1016/j.ebiom.2022.103908
Adak, A., & Khan, M. R. (2019). An insight into gut microbiota and its functionalities. Cellular and Molecular Life Sciences, 76(3), 473–493. https://doi.org/10.1007/s00018-018-2943-4
Chen, Y., Zhou, J., & Wang, L. (2021). Role and mechanism of gut microbiota in human disease. Frontiers in Cellular and Infection Microbiology, 11, 625913. https://doi.org/10.3389/fcimb.2021.625913
Kim, Y. C., Sohn, K. H., & Kang, H. R. (2024). Gut microbiota dysbiosis and its impact on asthma and other lung diseases: Potential therapeutic approaches. Korean Journal of Internal Medicine, 39(5), 746–758.https://doi.org/10.3904/kjim.2023.451
Cani, P. D., & Delzenne, N. M. (2007). Gut microflora as a target for energy and metabolic homeostasis. Current Opinion in Clinical Nutrition and Metabolic Care, 10(6),729–734.https://doi.org/10.1097/MCO.0b013e3282efdebb
Dave, M., Higgins, P. D., Middha, S., & Rioux, K. P. (2012). The human gut microbiome: Current knowledge, challenges, and future directions. Translational Research, 160(4),246–257.https://doi.org/10.1016/j.trsl.2012.05.003
Baritaki, S., de Bree, E., Chatzaki, E., & Pothoulakis, C. (2019). Chronic stress, inflammation, and colon cancer: A CRH system-driven molecular crosstalk. Journal of Clinical Medicine, 8(10), 1669. https://doi.org/10.3390/jcm8101669
Cryan, J. F., & O'Mahony, S. M. (2011). The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterology & Motility, 23(3), 187–192. https://doi.org/10.1111/j.1365-2982.2010.01664.x
Bellavance, M. A., & Rivest, S. (2014). The HPA-immune axis and the immunomodulatory actions of glucocorticoids in the brain. Frontiers in Immunology, 5,136.https://doi.org/10.3389/fimmu.2014.00136
Jacobson, L. (2005). Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinology and Metabolism Clinics of North America, 34(2), 271–292. https://doi.org/10.1016/j.ecl.2005.01.003
Leigh, S. J., Uhlig, F., Wilmes, L., Sanchez-Diaz, P., Gheorghe, C. E., Goodson, M. S., Kelley-Loughnane, N., Hyland, N. P., Cryan, J. F., & Clarke, G. (2023). The impact of acute and chronic stress on gastrointestinal physiology and function: A microbiota-gut- brain axis perspective. The Journal of Physiology, 601(20), 4491–4538. https://doi.org/10.1113/JP281951
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N. N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., ... Ohno, H. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504(7480),446–450.https://doi.org/10.1038/nature12721
Palepu, M. S. K., Gajula, S. N. R., K. M., Sonti, R., & Dandekar, M. P. (2024). SCFAs supplementation rescues anxiety- and depression-like phenotypes generated by fecal engraftment of treatment-resistant depression rats. ACS Chemical Neuroscience, 15(5), 1010–1025.https://doi.org/10.1021/acschemneuro.3c00727
Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209.
Chen, M. M., Wang, P., Xie, X. H., et al. (2023). Young adults with major depression show altered microbiome. Neuroscience, 522, 23–32. https://doi.org/10.1016/j.neuroscience.2023.05.002
Bengmark, S. (2013). Gut microbiota, immune development and function. Pharmacological Research, 69(1),87–113.https://doi.org/10.1016/j.phrs.2012.09.002
Gareau, M. G., Silva, M. A., & Perdue, M. H. (2008). Pathophysiological mechanisms of stress-induced intestinal damage. Current Molecular Medicine, 8(4), 274–281. https://doi.org/10.2174/156652408784533760
Moloney, R. D., Desbonnet, L., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014). The microbiome: Stress, health and disease. Mammalian Genome, 25(1–2), 49–74. https://doi.org/10.1007/s00335-013-9488-5
Maes, M., Kubera, M., & Leunis, J. C. (2008). The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram-negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinology Letters, 29(1), 117–124.
Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., Graef, D., Ettle, B., Vidal, A., Ratzka, A., & Gasser, T. (2018). Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease. Cell Stem Cell, 23(1), 123–131.e6.https://doi.org/10.1016/j.stem.2018.06.015
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D. H., May, C., Wilck, N., Balogh, A., Ostermann, L., Scheiermann, J., Bischof, A., Reimann, A., Schweiger, M., Gold, R., & Linker, R. A. (2015). Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity, 43(4),817–829.https://doi.org/10.1016/j.immuni.2015.09.007
Kessler, R. C. (1997). The effects of stressful life events on depression. Annual Review of Psychology, 48,191–214.https://doi.org/10.1146/annurev.psych.48.1.191
Hammen, C. (2005). Stress and depression. Annual Review of Clinical Psychology, 1, 293–319.https://doi.org/10.1146/annurev.clinpsy.1.102803.143938
De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A. J., Green, W., Denou, E., Silva, M. A., Santacruz, A., Sanz, Y., Surette, M. G., Verdu, E. F., Collins, S. M., & Bercik, P. (2015). Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nature Communications, 6, 7735. https://doi.org/10.1038/ncomms8735
Nemani, K., Hosseini Ghomi, R., McCormick, B., & Fan, X. (2015). Schizophrenia and the gut-brain axis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 56, 155–160.https://doi.org/10.1016/j.pnpbp.2014.08.018
Bastiaanssen, T. F. S., Cussotto, S., Claesson, M. J., Clarke, G., Dinan, T. G., & Cryan, J. F. (2020). Gutted! Unraveling the role of the microbiome in major depressive disorder. Harvard Review of Psychiatry, 28(1), 26–39. https://doi.org/10.1097/HRP.0000000000000243
Maldonado, R., Cabañero, D., & Martín-García, E. (2020). The endocannabinoid system in modulating fear, anxiety, and stress. Dialogues in Clinical Neuroscience, 22(3),229–239.https://doi.org/10.31887/DCNS.2020.22.3/rmaldonado
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264–276. https://doi.org/10.1016/j.cell.2015.02.047
Bailey, M. T., Dowd, S. E., Galley, J. D., Hufnagle, A. R., Allen, R. G., & Lyte, M. (2011). Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation. Brain, Behavior, and Immunity, 25(3),397–407.https://doi.org/10.1016/j.bbi.2010.10.023
Deleu, S., Machiels, K., Raes, J., Verbeke, K., & Vermeire, S. (2021). Short chain fatty acids and its producing organisms: An overlooked therapy for IBD? EBioMedicine, 66, 103293.https://doi.org/10.1016/j.ebiom.2021.103293
Maltz, R. M., Keirsey, J., Kim, S. C., Mackos, A. R., Gharaibeh, R. Z., Moore, C. C., & Bailey, M. T. (2018). Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids. PLoS ONE, 13(5), e0196961. https://doi.org/10.1371/journal.pone.0196961
Macrea, C., Ilias, T., Fratila, O., Roxana, B., & Hocopan, C. (2023). Probiotics and the microbiota-gut-brain axis: Focus on patients with depression. A review of current research. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic, 167(3),219–224.https://doi.org/10.5507/bp.2023.024
Gambaro, E., Gramaglia, C., Baldon, G., Luciani, M., Vanni, G., & Zeppegno, P. (2020). "Gut-brain axis": Review of the role of the probiotics in anxiety and depressive disorders. Brain and Behavior, 10(10),e01803.https://doi.org/10.1002/brb3.1803
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aleksandra Marciszewska, Natalia Popczyk, Hanna Tymchenko, Martyna Świątecka, Jakub Kaźmierczyk, Ewa Buczkowska, Jakub Jopek, Michał Popczyk, Agnieszka Piechowicz, Weronika Cionżyńska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

